Tabradol (Fusion Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Tabradol drug offered from Fusion Pharmaceuticals LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fusion Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | Cyclobenzaprine Hydrochloride |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-09-17 |
END MARKETING DATE: | 0000-00-00 |
Tabradol HUMAN PRESCRIPTION DRUG Details:
Item Description | Tabradol from Fusion Pharmaceuticals LLC |
LABELER NAME: | Fusion Pharmaceuticals LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2009-09-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43093-101_28c7b9e3-07ca-6f9b-e054-00144ff88e88 |
PRODUCT NDC: | 43093-101 |
APPLICATION NUMBER: |